In the light of the reported regional distribution of [18F]THK5317 retention in AD patients in comparison to controls [18] and previous in vitro work showing the good binding affinity of the tracer to tau deposits [16], we hypothesize that our findings illustrate the presence of tau pathology in neocortical regions that is related to cognitive impairment. Here, MAPT is linked to Cognitive impairment.